Cargando…

Novel perspectives on non-canonical inflammasome activation

Inflammasomes are cytosolic multi-protein complexes that regulate the secretion of the proinflammatory cytokines, IL-1β and IL-18, and induce pyroptosis, an inflammatory form of cell death. The NLRP3 inflammasome is the most well-characterized member of this family and functions by sensing intracell...

Descripción completa

Detalles Bibliográficos
Autores principales: Diamond, Catherine Emma, Khameneh, Hanif Javanmard, Brough, David, Mortellaro, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918253/
https://www.ncbi.nlm.nih.gov/pubmed/27471719
http://dx.doi.org/10.2147/ITT.S57976
_version_ 1782439088532488192
author Diamond, Catherine Emma
Khameneh, Hanif Javanmard
Brough, David
Mortellaro, Alessandra
author_facet Diamond, Catherine Emma
Khameneh, Hanif Javanmard
Brough, David
Mortellaro, Alessandra
author_sort Diamond, Catherine Emma
collection PubMed
description Inflammasomes are cytosolic multi-protein complexes that regulate the secretion of the proinflammatory cytokines, IL-1β and IL-18, and induce pyroptosis, an inflammatory form of cell death. The NLRP3 inflammasome is the most well-characterized member of this family and functions by sensing intracellular pathogen- and damage-associated molecular patterns and activating caspase-1, which processes the biologically inactive IL-1β and IL-18 precursors into active cytokines. Recent studies have identified an alternative mechanism of inflammasome activation, termed the non-canonical inflammasome, which is triggered by cytosolic sensing of lipopolysaccharide (LPS) derived from bacteria that have escaped phagolysosomes. This pathway is independent of Toll-like receptor 4 (TLR4), the well-known extracellular receptor for LPS, but instead depends on the inflammatory protease, caspase-11. Although our understanding of caspase-11 activation is still in its infancy, it appears to be an essential mediator of septic shock and attenuates intestinal inflammation. In this review, we bring together the latest data on the roles of caspase-11 and the mechanisms underlying caspase-11-mediated activation of the non-canonical inflammasome, and consider the implications of this pathway on TLR4-independent immune responses to LPS.
format Online
Article
Text
id pubmed-4918253
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-49182532016-07-28 Novel perspectives on non-canonical inflammasome activation Diamond, Catherine Emma Khameneh, Hanif Javanmard Brough, David Mortellaro, Alessandra Immunotargets Ther Review Inflammasomes are cytosolic multi-protein complexes that regulate the secretion of the proinflammatory cytokines, IL-1β and IL-18, and induce pyroptosis, an inflammatory form of cell death. The NLRP3 inflammasome is the most well-characterized member of this family and functions by sensing intracellular pathogen- and damage-associated molecular patterns and activating caspase-1, which processes the biologically inactive IL-1β and IL-18 precursors into active cytokines. Recent studies have identified an alternative mechanism of inflammasome activation, termed the non-canonical inflammasome, which is triggered by cytosolic sensing of lipopolysaccharide (LPS) derived from bacteria that have escaped phagolysosomes. This pathway is independent of Toll-like receptor 4 (TLR4), the well-known extracellular receptor for LPS, but instead depends on the inflammatory protease, caspase-11. Although our understanding of caspase-11 activation is still in its infancy, it appears to be an essential mediator of septic shock and attenuates intestinal inflammation. In this review, we bring together the latest data on the roles of caspase-11 and the mechanisms underlying caspase-11-mediated activation of the non-canonical inflammasome, and consider the implications of this pathway on TLR4-independent immune responses to LPS. Dove Medical Press 2015-07-24 /pmc/articles/PMC4918253/ /pubmed/27471719 http://dx.doi.org/10.2147/ITT.S57976 Text en © 2015 Diamond et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited.
spellingShingle Review
Diamond, Catherine Emma
Khameneh, Hanif Javanmard
Brough, David
Mortellaro, Alessandra
Novel perspectives on non-canonical inflammasome activation
title Novel perspectives on non-canonical inflammasome activation
title_full Novel perspectives on non-canonical inflammasome activation
title_fullStr Novel perspectives on non-canonical inflammasome activation
title_full_unstemmed Novel perspectives on non-canonical inflammasome activation
title_short Novel perspectives on non-canonical inflammasome activation
title_sort novel perspectives on non-canonical inflammasome activation
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918253/
https://www.ncbi.nlm.nih.gov/pubmed/27471719
http://dx.doi.org/10.2147/ITT.S57976
work_keys_str_mv AT diamondcatherineemma novelperspectivesonnoncanonicalinflammasomeactivation
AT khamenehhanifjavanmard novelperspectivesonnoncanonicalinflammasomeactivation
AT broughdavid novelperspectivesonnoncanonicalinflammasomeactivation
AT mortellaroalessandra novelperspectivesonnoncanonicalinflammasomeactivation